|
| | Publication Year | Title | Author(s) |
| 441 | 1-Jul-2021 | Response Evaluation and Survival Prediction After PD-1 Immunotherapy in Patients with Non-Small Cell Lung Cancer: Comparison of Assessment Methods. | Ayati, Narjess ; Lee, Sze Ting ; Zakavi, S Rasoul; Cheng, Melissa; Lau, W F Eddie; Parakh, Sagun ; Pathmaraj, Kunthi ; Scott, Andrew M |
| 442 | 27-Nov-2020 | Response evaluation and survival prediction following PD-1 immunotherapy in patients with non-small-cell lung cancer: comparison of assessment methods. | Ayati, Narjess ; Lee, Sze Ting ; Zakavi, Seyed Rasoul; Cheng, Melissa; Lau, Eddie ; Parakh, Sagun ; Pathmaraj, Kunthi ; Scott, Andrew M |
| 443 | Sep-2020 | Response to combined BRAF/MEK inhibition in adult BRAF V600E mutant spinal pilocytic astrocytoma. | Balasubramanian, Adithya ; Gunjur, Ashray ; Gan, Hui Kong; Perchyonok, Yuliya ; Cher, Lawrence M |
| 444 | 10-Nov-2014 | Response to MAPK pathway inhibitors in BRAF V600M-mutated metastatic melanoma. | Parakh, S ; Murphy, C; Lau, D ; Cebon, Jonathan S ; Andrews, Miles C |
| 145 | Dec-2019 | RET-rearranged non-small-cell lung cancer and therapeutic implications. | Loh, Zoe ; Mitchell, Paul L R ; John, Thomas ; Arulananda, Surein |
| 146 | 12-Nov-2018 | Rheumatic immune-related adverse events secondary to anti-programmed death-1 antibodies and preliminary analysis on the impact of corticosteroids on anti-tumour response: A case series. | Mitchell, Emma L; Lau, Peter Kar Han; Khoo, Chloe; Liew, David F; Leung, Jessica; Liu, Bonnia ; Rischin, Adam; Frauman, Albert G ; Kee, Damien ; Smith, Kortnye; Brady, Benjamin; Rischin, Danny; Gibson, Andrew; Mileshkin, Linda; Klein, Oliver ; Weickhardt, Andrew; Arulananda, Surein; Shackleton, Mark; McArthur, Grant; Östör, Andrew; Cebon, Jonathan S ; Solomon, Benjamin; Buchanan, Russell R C ; Wicks, Ian P; Lo, Serigne; Hicks, Rodney J; Sandhu, Shahneen |
| 147 | 21-Nov-2014 | RHOA inactivation enhances Wnt signalling and promotes colorectal cancer. | Rodrigues, Paulo; Macaya, Irati; Bazzocco, Sarah; Mazzolini, Rocco; Andretta, Elena; Dopeso, Higinio; Mateo-Lozano, Silvia; Bilić, Josipa; Cartón-García, Fernando; Nieto, Rocio; Suárez-López, Lucia; Afonso, Elsa; Landolfi, Stefania; Hernandez-Losa, Javier; Kobayashi, Kazuto; Cajal, Santiago Ramón Y; Tabernero, Josep; Tebbutt, Niall C ; Mariadason, John M ; Schwartz, Simo; Arango, Diego |
| 148 | Jun-2019 | Right or Left Primary Site of Colorectal Cancer: Outcomes From the Molecular Analysis of the AGITG MAX Trial. | Tapia Rico, Gonzalo; Price, Timothy; Tebbutt, Niall C ; Hardingham, Jennifer; Lee, Chee; Buizen, Luke; Wilson, Kate; Gebski, Val; Townsend, Amanda |
| 149 | Nov-2017 | Rilotumumab plus epirubicin, cisplatin, and capecitabine as first-line therapy in advanced MET-positive gastric or gastro-oesophageal junction cancer (RILOMET-1): a randomised,
double-blind, placebo-controlled, phase 3 trial. | Catenacci, Daniel V T; Tebbutt, Niall C ; Davidenko, Irina; Murad, André M; Al-Batran, Salah-Eddin; Ilson, David H; Tjulandin, Sergei; Gotovkin, Evengy; Karaszewska, Boguslawa; Bondarenko, Igor; Tejani, Mohamedtaki A; Udrea, Anghel A; Tehfe, Mustapha; De Vita, Ferdinando; Turkington, Cheryl; Tang, Rui; Ang, Agnes; Zhang, Yilong; Hoang, Tien; Sidhu, Roger; Cunningham, David |
| 150 | 27-Jan-2011 | Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab. | Tebbutt, Niall C ; Murphy, F; Zannino, D; Wilson, K; Cummins, M M; Abdi, E; Strickland, A H; Lowenthal, R M; Marx, G; Karapetis, C; Shannon, J; Goldstein, David B; Nayagam, S S; Blum, R; Chantrill, L; Simes, R J; Price, Timothy J |
| 151 | Apr-2021 | The role of BCL-2 family proteins and therapeutic potential of BH3-mimetics in malignant pleural mesothelioma. | Arulananda, Surein; Lee, Erinna F; Fairlie, Walter Douglas ; John, Thomas |
| 152 | 26-Nov-2020 | The role of BCL-2 family proteins and therapeutic potential of BH3-mimetics in malignant pleural mesothelioma. | Arulananda, Surein; Lee, Erinna F; Fairlie, W Douglas; John, Thomas |
| 153 | 29-Jul-2014 | The role of biological therapy in metastatic colorectal cancer after first-line treatment: a meta-analysis of randomised trials. | Segelov, E; Chan, David L; Shapiro, J; Price, Timothy J; Karapetis, C S; Tebbutt, Niall C ; Pavlakis, N |
| 154 | 23-Jul-2013 | The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer. | John, Thomas ; Starmans, Maud H W; Chen, Yao-Tseng; Russell, Prudence A; Barnett, Stephen A ; White, Shane C; Mitchell, Paul L R ; Walkiewicz, Marzena; Azad, Arun A; Lambin, Philippe; Tsao, Ming-Sound; Deb, Siddhartha; Altorki, Nasser; Wright, Gavin; Knight, Simon R ; Boutros, Paul C; Cebon, Jonathan S |
| 155 | 1-Apr-2015 | Role of immunotherapy in lung cancer: Preliminary results of new vaccines and immune checkpoint inhibitors. | John, Thomas |
| 156 | 10-Nov-2007 | Role of low-dose, noncontrast computed tomography from integrated positron emission tomography/computed tomography in evaluating incidental 2-deoxy-2-[F-18]fluoro-D-glucose-avid colon lesions. | Lee, S T; Tan, T; Poon, A M T; Toh, H B; Gill, S; Berlangieri, Salvatore U ; Kraft, E; Byrne, Amanda J; Pathmaraj, K ; O'Keefe, Graeme J; Tebbutt, Niall C ; Scott, Andrew M |
| 157 | 2019 | Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial. | Lassman, Andrew B; van den Bent, Martin J; Gan, Hui K ; Reardon, David A; Kumthekar, Priya; Butowski, Nicholas; Lwin, Zarnie; Mikkelsen, Tom; Nabors, Louis B; Papadopoulos, Kyriakos P; Penas-Prado, Marta; Simes, John; Wheeler, Helen; Walbert, Tobias; Scott, Andrew M ; Gomez, Erica; Lee, Ho-Jin; Roberts-Rapp, Lisa; Xiong, Hao; Ansell, Peter J; Bain, Earle; Holen, Kyle D; Maag, David; Merrell, Ryan |
| 158 | 18-May-2018 | Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma. | Gan, Hui K ; Reardon, David A; Lassman, Andrew B; Merrell, Ryan; van den Bent, Martin; Butowski, Nicholas; Lwin, Zarnie; Wheeler, Helen; Fichtel, Lisa; Scott, Andrew M ; Gomez, Erica J; Fischer, JuDee; Mandich, Helen; Xiong, Hao; Lee, Ho-Jin; Munasinghe, Wijith P; Roberts-Rapp, Lisa A; Ansell, Peter J; Holen, Kyle D; Kumthekar, Priya |
| 159 | Jun-2021 | Salvage treatment using anti-PD-1/CTLA-4 immunotherapy after failure of neoadjuvant chemotherapy in microsatellite instable gastroesophageal carcinoma. | Klein, Oliver ; Brown, Wendy A; Saxon, Sarah; Haydon, Andrew |
| 160 | Dec-2023 | SCORE: a randomised controlled trial evaluating shared care (general practitioner and oncologist) follow-up compared to usual oncologist follow-up for survivors of colorectal cancer. | Jefford, Michael; Emery, Jon D; James Martin, Andrew; De Abreu Lourenco, Richard; Lisy, Karolina; Grunfeld, Eva; Mohamed, Mustafa Abdi; King, Dorothy; Tebbutt, Niall C ; Lee, Margaret; Mehrnejad, Ashkan; Burgess, Adele N ; Marker, Julie; Eggins, Renee; Carrello, Joseph; Thomas, Hayley; Schofield, Penelope |
